Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Net-Receivables" stands at 11.92 Billion Swiss Francs as of 06/30/2025, the lowest value since 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.09 percent compared to the value the year prior.
The 1 year change in percent is -2.09.
The 3 year change in percent is 7.58.
The 5 year change in percent is 0.5314.
The 10 year change in percent is 46.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |
![]() | Novartis AG - Net Receivables | 255,096,620,580.91 |